(Q43805751)

27 November 2017

title

Increased electroretinogram a-wave amplitude after intravitreal bevacizumab injection for neovascular age-related macular degeneration (English)

1 reference

27 November 2017

1 reference

Alon Skaat

1

1 reference

27 November 2017

Arie Solomon

2

1 reference

27 November 2017

Iris Moroz

3

1 reference

27 November 2017

Orit Vidne Hai

4

1 reference

27 November 2017

Ehud Rechtman

5

1 reference

27 November 2017

Vicktoria Vishnevskia Dai

6

1 reference

27 November 2017

Ygal Rotenstreich

7

1 reference

27 November 2017

publication date

14 October 2010

1 reference

27 November 2017

1 reference

27 November 2017

volume

89

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

e269-73

1 reference

ISCEV Standard for Clinical Electro-oculography (EOG) 2006

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Prevalence of age-related macular degeneration in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Beta wave of the scotopic (rod) electroretinogram as a measure of the activity of human on-bipolar cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Cone Dysfunction in Patients With Late-Onset Cone Dystrophy and Age-Related Macular Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Photoreceptor and bipolar cell contributions to the cat electroretinogram: a kinetic model for the early part of the flash response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.02005.X

10.1111/J.1755-3768.2010.02005.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference